刘娟娟，女，2019年毕业于中国科学技术大学并获得博士学位；2019-2022年于中国科学院合肥物质科学研究院从事博士后研究工作，主要研究方向为膜蛋白靶向抗体药物开发及应用研究。2022年加入合肥综合性国家科学中心大健康研究院。以第一及共一作者在EMBO Report、Peer J等期刊杂志发表学术论文，并参与发表了多篇发明专利。

主要研究方向是针对炎症调控及癌症发生相关的G蛋白家族成员进行膜蛋白靶向抗体药物的开发，利用抗体药物进行疾病治疗及癌症干预。

1. Lei Zhu; Hongxin Zhao; Juanjuan Liu; Hao Cai; Bo Wu; Zhijun Liu; Shu Zhou; Qingsong Liu; Xiaokun Li; Bin Bao; Jian Liu; Han Dai; Junfeng Wang ; Dynamic folding modulation generates FGF21 variant against diabetes, EMBO Reports, 2020, 2251352: 1-10

2. Juanjuan Liu; Lei Zhu; Xueli Zhang; Bo Wu; Ping Zhu; Hongxin Zhao; Junfeng Wang ;Peptide-based NTANi-nanodiscs for studying membrane enhanced FGFR1 kinase activities, PeerJ, 2019, 7

3. Guangyao Huang; Hongxin Zhao; Pan Li; Juanjuan Liu; Siyu Chen; Meihong Ge; Miao Qin; Guoliang Zhou; Yongtao Wang; Shaofei Li; Yizhuang Cheng; Qiang Huang; Junfeng Wang; Hongzhi Wang; Liangbao Yang ; Construction of Optimal SERS Hotspots Based on Capturing the Spike Receptor[1]Binding Domain RBD of SARS-CoV-2 for Highly Sensitive and Specific Detection by a Fish Model,

Analytical Chemistry, 2021, 9348: 16086-16095

4. Lina Zhu; Hongxin Zhao; Yizhuo Wang; Chuandi Yu; Juanjuan Liu ; Ling Li; Zehua Li; Jin Zhang; Han Dai; Junfeng Wang; Lei Zhu ; Solubilization, purification, and ligand binding characterization of G protein-coupled receptor SMO in native membrane bilayer using styrene maleic acid copolymer, PeerJ, 2022, 10: e13381-e13381

5. Chuandi Yu; Wen Ding; Lei Zhu; Yuhang Zhou; Yingkui Dong; Ling Li; Juanjuan Liu; Yizhuo Wang; Zehua Li; Lina Zhu; FaJun Chen; Maosen Ruan; Dongming Qian; Yujuan Wang; Bo Wu; Huangtao Xu; Ming Li; Yunchen Bi; Hao Wang; Weiqian Wang; Peng Chao; Lei Xing; Bing Shen; Han Dai; Lisha Zha; Hongxin Zhao; Junfeng Wang ; Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins, iScience, 2023, 261: 105736